48Hour Discovery Alternatives & Competitors
12 companies similar to 48Hour Discovery — Advancing Peptide Drug Development
Companies similar to 48Hour Discovery
PepLib
Rethink Peptide Drug Discovery: Universal-Exact-Diverse
Zhuzhou, China
Orbit Discovery
Delivering Peptide Enabled Drug Discovery Solutions
Oxford, United Kingdom
Design Pharmaceuticals Inc.
Boundless GPCR drug discovery
Cambridge, United States
Deargen
AI-First Pharmatech Company. We are exploring sequence-based drug discovery and developmen...
Daejeon, Korea South
Track all 48Hour Discovery competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Thelial Technologies
Discovering and developing targeted carcinoma therapies through innovative drug discovery...
Envisagenics
Artificial Intelligence, High Performance Computing, and RNA sequencing data to find cures...
New York, United States
Accutar Biotech
Employ AI to Revolutionize Drug Discovery
Brooklyn, United States
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
Circle Pharma, Inc.
A New Paradigm For Macrocycle Drug Development
South San Francisco, Unit...
Halda Therapeutics
Taking Hold, Conquering Cancer. Discovering novel medicines to target cancer and overcome...
New Haven, United States
Cellarity
Rewriting the rules of drug creation
Somerville, United States
ONCOCROSS Co., Ltd.
AI, drug discovery development, biotechnology, indication expansion, rare disease, intract...
Seoul, Korea South
About 48Hour Discovery
48Hour Discovery, founded in 2017, is a pioneering company in the Biotechnology sector, dedicated to revolutionizing peptide-based drug discovery. Embracing their slogan, "Advancing Peptide Drug Development," the company is streamlining the process of developing new therapies. Their cutting-edge platform focuses on red...
Peptide Discovery, Drug Lead Advancement, Customization in Drug Discovery, Synthesis, Validation, and Optimization of Peptides, Protein and Cell-based Screening
Emerging Startups, Global Pharmaceutical Companies, Clinical-stage Radiopharmaceutical Firms
Peptide Drug Discovery, Target Screening Strategy, Drug Lead Identification, Peptide-derived Molecules, Genetically-Encoded Peptides, Chemically Modified Peptides, Peptide-based Therapies, Drug Development Innovation, Rapid Ligand Identification, Cost-effective Drug Development, Risk Mitigation In Drug Discovery, Customizable Peptide Libraries, Flexible Pricing Models, Royalty-free Results, Biotechnology Platform
B2B, Platform, SaaS
Licensing, Project Based, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches 48Hour Discovery and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at 48Hour Discovery on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
